Healthy New Jersey

Information on
Novel Coronavirus

Have questions about COVID-19?
The NJ Poison Control Center and 211 have partnered with the State to provide information to the public on COVID-19:
Call: 2-1-1 for general information (24/7) or 1-800-962-1253 for medical information (24/7)
Text: NJCOVID to 898-211
Visit covid19.nj.gov or nj.gov/health for additional information

Division of Medicinal Marijuana

Medicinal Marijuana Review Panel

The purpose of the Medicinal Marijuana Review Panel is to review petitions and make recommendations to the Commissioner of the Department of Health regarding the approval or denial of a petition requesting approval of other medical conditions or treatment thereof as debilitating medical conditions.

Review Panel Information

Review Panel Members

    • Alex Bekker, MD, Phd – Chairperson
    • Cheryl Kennedy, MD   - Vice Chairperson
    • Mary Bridgeman, PharmD
    • Mary Johansen, Phd, NE-BC, RN
    • Petros Levounis, MD, MA
    • Jessica Scerbo, MD
    • Stephanie Zarus, PharmD

Panel Recommendations

  • Following a period of public comment, the Medicinal Marijuana Review Panel's initial recommendations to the Commissioner of Health for adding new qualifying conditions to the Medicinal Marijuana Program were finalized at its October 25, 2017 meeting. The Office of the Commissioner of the Department of Health has 180 days from that date to accept or reject those recommendations.

    View Panel Recommendations


Back
to top